Baijin Life Science Schedules 30 June Board Meeting to Approve FY 2026 Results and Discuss Final Dividend

Bulletin Express

06/17

Baijin Life Science Holdings Limited has announced that its board of directors will convene on 30 June 2026. The primary agenda includes approving the consolidated final results for the financial year ended 31 March 2026 and deliberating on a potential final dividend payout.

According to the 17 June 2026 filing, the meeting will involve the company’s executive directors Cheung Sze Ming, Dong Peng and Dr. Su Yaoyao; non-executive directors Zhu Yongjun, Cheng Chi Kin and Xie Chunchen; and independent non-executive directors Wong Siu Keung Joe, Chang Chunyu and Shen Ding.

No further financial figures or dividend amounts were disclosed in the announcement. A formal results announcement is expected following the board meeting.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1130475508"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1130475508\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1130475508?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-17 17:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1130475508","market":"hk","top_or_hot":-1,"title":"Baijin Life Science Schedules 30 June Board Meeting to Approve FY 2026 Results and Discuss Final Dividend","media":"Bulletin Express","content":"<p>Baijin Life Science Holdings Limited has announced that its board of directors will convene on 30 June 2026. The primary agenda includes approving the consolidated final results for the financial year ended 31 March 2026 and deliberating on a potential final dividend payout.</p>\n<p>According to the 17 June 2026 filing, the meeting will involve the company’s executive directors Cheung Sze Ming, Dong Peng and Dr. Su Yaoyao; non-executive directors Zhu Yongjun, Cheng Chi Kin and Xie Chunchen; and independent non-executive directors Wong Siu Keung Joe, Chang Chunyu and Shen Ding.</p>\n<p>No further financial figures or dividend amounts were disclosed in the announcement. A formal results announcement is expected following the board meeting.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Baijin Life Science Schedules 30 June Board Meeting to Approve FY 2026 Results and Discuss Final Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBaijin Life Science Schedules 30 June Board Meeting to Approve FY 2026 Results and Discuss Final Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-17 17:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Baijin Life Science Holdings Limited has announced that its board of directors will convene on 30 June 2026. The primary agenda includes approving the consolidated final results for the financial year ended 31 March 2026 and deliberating on a potential final dividend payout.</p>\n<p>According to the 17 June 2026 filing, the meeting will involve the company’s executive directors Cheung Sze Ming, Dong Peng and Dr. Su Yaoyao; non-executive directors Zhu Yongjun, Cheng Chi Kin and Xie Chunchen; and independent non-executive directors Wong Siu Keung Joe, Chang Chunyu and Shen Ding.</p>\n<p>No further financial figures or dividend amounts were disclosed in the announcement. A formal results announcement is expected following the board meeting.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01466","symbol_name":"佰金生命科学","start_time":0,"source_url":"","article_id":"1130475508","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1130475508","pubTimestamp":1781688339,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Baijin Life Science Holdings Limited has announced that its board of directors will convene on 30 June 2026. The primary agenda includes approving the consolidated final results for the financial...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01466":"佰金生命科学"},"translate_title":"百金生命科学定于6月30日召开董事会批准2026财年业绩并讨论末期股息","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01466":1},"content_text":"Baijin Life Science Holdings Limited has announced that its board of directors will convene on 30 June 2026. The primary agenda includes approving the consolidated final results for the financial year ended 31 March 2026 and deliberating on a potential final dividend payout.\nAccording to the 17 June 2026 filing, the meeting will involve the company’s executive directors Cheung Sze Ming, Dong Peng and Dr. Su Yaoyao; non-executive directors Zhu Yongjun, Cheng Chi Kin and Xie Chunchen; and independent non-executive directors Wong Siu Keung Joe, Chang Chunyu and Shen Ding.\nNo further financial figures or dividend amounts were disclosed in the announcement. A formal results announcement is expected following the board meeting.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}